Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bleeding Symptoms of Carriers of Hemophilia A and B

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Anna Olsson, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01029808
First received: December 9, 2009
Last updated: October 18, 2016
Last verified: October 2016

December 9, 2009
October 18, 2016
December 2009
July 2011   (final data collection date for primary outcome measure)
Bleeding tendency in carriers of severe and moderate haemophilia compared to a control group. [ Time Frame: Five years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01029808 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bleeding Symptoms of Carriers of Hemophilia A and B
Bleeding Symptoms of Carriers of Hemophilia A and B
To collect and analyze data on female carriers of severe and moderate hemophilia A and B.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Carriers of severe and moderate hemophilia A and B
Hemophilia
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
126
July 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Female carriers of hemophilia A and B.

Exclusion Criteria:

  • Pregnancy.
Female
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01029808
VGAO002
No
Not Provided
Not Provided
Anna Olsson, Sahlgrenska University Hospital, Sweden
Sahlgrenska University Hospital, Sweden
Not Provided
Study Chair: Fariba Baghaei, MD PhD
Sahlgrenska University Hospital, Sweden
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP